Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States

Clinical and Vaccine Immunology

Volumn 21, Issue 2, 2014, Pages 119-125

  Pawloski, L C ^a   Queenan, A M ^b   Cassiday, P K ^a   Lynch, A S ^b   Harrison, M J ^a   Shang, W ^b   Williams, M M ^a   Bowden, K E ^a   Burgos Rivera, B ^a   Qin, X ^c   Messonnier, N ^a   Tondella, M L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; BORDETELLA PERTUSSIS; CLUSTER ANALYSIS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA; UNITED STATES; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 84893212053     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00717-13     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. 2012. National Notifiable Diseases Surveillance System. Division of Notifiable Diseases and Healthcare Information, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, GA.
2. Centers for Disease Control and Prevention. 2012. Pertussis epidemic - Washington, 2012. MMWR Morb. Mortal. Wkly. Rep. 61:517-522.
3. Clark TA, Messonnier NE, Hadler SC. 2012. Pertussis control: time for something new? Trends Microbiol. 20:211-213. http://dx.doi.org/10.1016/j.tim. 2012.03.003.
4. Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. 2012. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 308:2126-2132. http://dx.doi.org/10.1001/jama.2012.14939.
5. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P. 2011. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect. Dis. 11:557-570. http://dx.doi.org/10.1016/S1473- 3099(11)70007-X.
6. Rendi-Wagner P, Tobias J, Moerman L, Goren S, Bassal R, Green M, Cohen D. 2010. The seroepidemiology of Bordetella pertussis in Israel - estimate of incidence of infection. Vaccine 28:3285-3290. http://dx.doi.org/10.1016/j. vaccine.2010.02.104.
7. de Greeff SC, de Melker HE, van Gageldonk PG, Schellekens JF, van der Klis FR, Mollema L, Mooi FR, Berbers GA. 2010. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 5:e14183. http://dx.doi.org/10.1371/journal.pone.0014183.
8. Bottero D, Gaillard ME, Basile LA, Fritz M, Hozbor DF. 2012. Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America. J. Appl. Microbiol. 112:1266-1276. http://dx.doi.org/10.1111/j.1365-2672.2012.05299.x.
9. Bouchez V, Caro V, Levillain E, Guigon G, Guiso N. 2008. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS One 3:e2437. http://dx.doi.org/10.1371/journal.pone. 0002437.
10. Kallonen T, Grondahl-Yli-Hannuksela K, Elomaa A, Lutynska A, Fry NK, Mertsola J, He Q. 2011. Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect. Genet. Evol. 11:2034-2042. http://dx.doi.org/10. 1016/j.meegid.2011.09.012.
11. Petersen RF, Dalby T, Dragsted DM, Mooi F, Lambertsen L. 2012. Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg. Infect. Dis. 18:767-774. http://dx.doi.org/10.3201/eid1805.110812.
12. Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM. 2012. Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg. Infect. Dis. 18:1248-1255. http://dx.doi.org/10.3201/eid1808. 120082.
13. Hegerle N, Paris AS, Brun D, Dore G, Njamkepo E, Guillot S, Guiso N. 2012. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin. Microbiol. Infect. 18:E340-E346. http://dx.doi.org/10.1111/j.1469-0691.2012.03925.x.
14. Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G, Lan R. 2012. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J. Infect. Dis. 205:1220-1224. http://dx.doi.org/10.1093/infdis/jis178.
15. van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Mooi FR. 2012. Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One 7:e46407. http://dx.doi.org/10.1371/journal.pone.0046407.
16. Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q. 2012. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin. Vaccine Immunol. 19:1703-1704. http://dx.doi.org/10. 1128/CVI.00367-12.
17. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N. 2009. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 27:6034-6041. http://dx.doi.org/10.1016/j. vaccine.2009.07.074.
18. Mastrantonio P, Spigaglia P, van Oirschot H, van der Heide HG, Heuvelman K, Stefanelli P, Mooi FR. 1999. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 145(Part 8):2069-2075. http://dx.doi.org/10.1099/13500872-145-8-2069. (Pubitemid 29396937)
19. Otsuka N, Han HJ, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, Shibayama K, Kamachi K. 2012. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One 7:e31985. http://dx.doi.org/10.1371/journal.pone.0031985.
20. Queenan AM, Cassiday PK, Evangelista A. 2013. Pertactin-negative variants of Bordetella pertussis in the United States. N. Engl. J. Med. 368:583-584. http://dx.doi.org/10.1056/NEJMc1209369.
21. Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, Chavez G. 2012. California pertussis epidemic, 2010. J. Pediatr. 161:1091-1096. http://dx.doi.org/10.1016/j.jpeds.2012.05.041.
22. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. 1998. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66:670-675. (Pubitemid 28074211)
23. Mooi FR, Hallander H, Wirsing von Konig CH, Hoet B, Guiso N. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19:174-181. http://dx.doi.org/10.1007/s100960050455. (Pubitemid 30201292)
24. Gee JE, Sacchi CT, Glass MB, De BK, Weyant RS, Levett PN, Whitney AM, Hoffmaster AR, Popovic T. 2003. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J. Clin. Microbiol. 41:4647-4654. http://dx.doi.org/10.1128/JCM.41.10.4647-4654. 2003. (Pubitemid 37259771)
25. McLafferty MA, Harcus DR, Hewlett EL. 1988. Nucleotide sequence and characterization of a repetitive DNA element from the genome of Bordetella pertussis with characteristics of an insertion sequence. J. Gen. Microbiol. 134:2297-2306.
26. Hardwick TH, Cassiday P, Weyant RS, Bisgard KM, Sanden GN. 2002. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg. Infect. Dis. 8:44-49. http://dx.doi.org/10.3201/eid0801.010021. (Pubitemid 34094280)
27. Cassiday P, Hussin A, Stiles T, Boxrud D, Bonkosky MM, Tondella ML. 2010. Pulsed-field gel electrophoresis profiles of Bordetella pertussis isolated in the United States: comparison between contemporary (2000-2009) and previously reported (1935-1999) strains. Proceedings of the 9th International Symposium on Bordetella, Baltimore, MD.
28. Cassiday PK, Skoff TH, Faulkner AE, Connolly L, Jawahir S, Tondella ML. 2013. Temporal changes in the predominance of pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates from the United States, 2000-2012. Proceedings of the 10th International Symposium on Bordetella, Dublin, Ireland.
29. Tatti KM, Sparks KN, Boney KO, Tondella ML. 2011. Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J. Clin. Microbiol. 49:4059-4066. http://dx.doi.org/10.1128/JCM. 00601-11.
30. Stefanelli P, Fazio C, Fedele G, Spensieri F, Ausiello CM, Mastrantonio P. 2009. A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells. New Microbiol. 32:159-166.
31. Hellwig SM, Rodriguez ME, Berbers GA, van de Winkel JG, Mooi FR. 2003. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J. Infect. Dis. 188:738-742. http://dx.doi.org/10.1086/377283. (Pubitemid 37115187)
32. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D. 2004. Type V protein secretion pathway: the autotransporter story. Microbiol. Mol. Biol. Rev. 68:692-744. http://dx.doi.org/10.1128/MMBR.68.4.692-744.2004.
33. Bodilis H, Guiso N. 2013. Virulence of pertactin-negative Bordetella pertussis isolates from infants, France. Emerg. Infect. Dis. 19:471-474. http://dx.doi.org/10.3201/eid1903.121475.
34. van der Ark AA, Hozbor DF, Boog CJ, Metz B, van den Dobbelsteen GP, van Els CA. 2012. Resurgence of pertussis calls for re-evaluation of pertussis animal models. Expert Rev. Vaccines 11:1121-1137. http://dx.doi.org/10.1586/erv. 12.83.